Menu Search
Equities

Fine Foods & Pharmaceuticals NTM SpA

9S5:FRA

Fine Foods & Pharmaceuticals NTM SpA

Actions
  • Price (EUR)8.06
  • Today's Change0.02 / 0.25%
  • Shares traded180.00
  • 1 Year change+5.77%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fine Foods & Pharmaceuticals NTM SpA, formerly Innova Italy 1 SpA, is an Italy-based pharmaceutical company. It is specialized in the manufacturing of pharmaceutical products for third parties. The Company manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

  • Revenue in EUR (TTM)247.19m
  • Net income in EUR2.61m
  • Incorporated--
  • Employees753.00
  • Location
    Fine Foods & Pharmaceuticals NTM SpAVia Berlino, 39, ZingoniaVERDELLINO 24040ItalyITA
  • Websitehttps://www.finefoods.it
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.